
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
来源:CNBC发布于 2026-11-16
Novo released full results from a late-stage trial showing Wegovy helped children ages 6 to under 12 with obesity significantly lower their body mass index. Wegovy is already approved to treat obesity...
相关标的:NVO
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。